- Home
- WFCF vs CRVO Comparison
WFCF vs CRVO Comparison
Compare WFCF & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFCF
- CRVO
- Stock Information
- Founded
- WFCF 1996
- CRVO 2001
- Country
- WFCF United States
- CRVO United States
- Employees
- WFCF N/A
- CRVO N/A
- Industry
- WFCF Computer Software: Prepackaged Software
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- WFCF Technology
- CRVO Health Care
- Exchange
- WFCF Nasdaq
- CRVO Nasdaq
- Market Cap
- WFCF 59.0M
- CRVO 67.4M
- IPO Year
- WFCF 2011
- CRVO N/A
- Fundamental
- Price
- WFCF $11.33
- CRVO $8.50
- Analyst Decision
- WFCF
- CRVO Strong Buy
- Analyst Count
- WFCF 0
- CRVO 6
- Target Price
- WFCF N/A
- CRVO $17.40
- AVG Volume (30 Days)
- WFCF 2.7K
- CRVO 786.6K
- Earning Date
- WFCF 08-07-2025
- CRVO 08-12-2025
- Dividend Yield
- WFCF N/A
- CRVO N/A
- EPS Growth
- WFCF N/A
- CRVO N/A
- EPS
- WFCF 0.38
- CRVO N/A
- Revenue
- WFCF $25,437,000.00
- CRVO $9,308,215.00
- Revenue This Year
- WFCF N/A
- CRVO N/A
- Revenue Next Year
- WFCF N/A
- CRVO N/A
- P/E Ratio
- WFCF $29.94
- CRVO N/A
- Revenue Growth
- WFCF N/A
- CRVO 15.14
- 52 Week Low
- WFCF $9.26
- CRVO $1.80
- 52 Week High
- WFCF $13.50
- CRVO $20.63
- Technical
- Relative Strength Index (RSI)
- WFCF 54.65
- CRVO 60.53
- Support Level
- WFCF $11.16
- CRVO $7.81
- Resistance Level
- WFCF $11.50
- CRVO $13.13
- Average True Range (ATR)
- WFCF 0.18
- CRVO 1.05
- MACD
- WFCF -0.02
- CRVO 0.16
- Stochastic Oscillator
- WFCF 55.82
- CRVO 26.27
About WFCF Where Food Comes From Inc.
Where Food Comes From Inc is a third-party food verification company. It offers food production audits and uses verification processes to ensure that claims made by food producers and processors are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including International Certification Services, Validus Verification Services, and others. The company operates in two segments that are verification and certification and Software Sales and Related Consulting. It generates the majority of its revenue from verification and certification.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.